Medicare AdvantageBilling CodesLow impact
MA05.021c, Injectable Dermal Fillers for Cosmetic Procedures
Independence Blue Cross·Dermatology, Infectious Disease, Plastic Surgery·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated policy MA05.021c for injectable dermal fillers effective 10/01/2025, replacing deleted ICD-10 code E88.1 (Lipodystrophy, not elsewhere classified) with E88.14 (HIV-associated lipodystrophy). The policy was reissued on 04/01/2026 with no substantive changes to coverage criteria. Coverage remains limited to Sculptra® and Radiesse® for HIV-associated facial lipodystrophy when depression is a significant contributor.
Action Required
By 10/01/2025: Billing team must update diagnosis code mappings in the billing system to replace E88.1 with E88.14 for HIV-associated lipodystrophy claims. Update claim validation logic and prior authorization templates to use E88.14 instead of E88.1. No changes to covered procedures, billing codes, or medical necessity criteria are required. Verify that claims submitted after 10/01/2025 with the new E88.14 code process without denials due to unrecognized diagnosis coding.